MAXENTRA

pharmaceutical preparations for the treatment of artheriosclerotic disease, autoimmune diseases, cancer, cardiovascular diseases, central nervous system diseases and disorders, cerebrovascular diseases, diabetes and other metabolic disorders, inflammation and inflammatory diseases, respiratory and infectious diseases, peripheral and central vascular diseases, seizure disorders, shock and central nervous system trauma, stroke, and viral diseases